control group:best supportive treatment and FOLFIRINOX

2 trials

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Conditions

Pancreatic cancer

Early Phase 1

A multicenter randomized controlled clinical study of Fuzheng Xiaoji pill in the treatment of metastatic pancreatic cancer

RecruitingITMCTR2000003298

Guang'anmen Hospital, China Academy of Chinese Medical SciencesPancreatic cancer

Start: 2020-05-06Updated: 2023-02-20

A multicenter randomized controlled clinical study of Fuzheng Xiaoji pill in the treatment of metastatic pancreatic cancer

RecruitingChiCTR2000032875

Guang'anmen Hospital, China Academy of Chinese Medical SciencesPancreatic cancer

Start: 2020-05-06Updated: 2020-05-18